These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1729765)

  • 1. Nickel-induced hyperglycaemia: the role of insulin and glucagon.
    Cartañà J; Arola L
    Toxicology; 1992; 71(1-2):181-92. PubMed ID: 1729765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 2-adrenergic blockade prevents hyperglycemia and hepatic glutathione depletion in nickel-injected rats.
    Alvarez C; Bladé C; Cartañà J
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):112-7. PubMed ID: 8101665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lithium on plasma glucose, insulin and glucagon in normal and streptozotocin-diabetic rats: role of glucagon in the hyperglycaemic response.
    Hermida OG; Fontela T; Ghiglione M; Uttenthal LO
    Br J Pharmacol; 1994 Mar; 111(3):861-5. PubMed ID: 8019763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.
    Burcelin R; Eddouks M; Maury J; Kande J; Assan R; Girard J
    Diabetologia; 1995 Mar; 38(3):283-90. PubMed ID: 7758874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
    Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
    Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased insulin action in cultured hepatocytes from rats with diabetes induced by neonatal streptozotocin.
    Melin B; Caron M; Cherqui G; Blivet MJ; Bailbe D; Picard J; Capeau J; Portha B
    Endocrinology; 1991 Apr; 128(4):1693-701. PubMed ID: 1848501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinlike effects of vanadate on hepatic glycogen metabolism in nondiabetic and streptozocin-induced diabetic rats.
    Pugazhenthi S; Khandelwal RL
    Diabetes; 1990 Jul; 39(7):821-7. PubMed ID: 2113014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and glucagon secretion in streptozotocin-diabetic rats: influences of islets transplanted to the renal subcapsular space.
    Ar'Rajab A; Ahrén B; Bengmark S
    Diabetes Res; 1989 Sep; 12(1):37-41. PubMed ID: 2517050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The possible role of age-related increase in the plasma glucagon/insulin ratio in the enhanced hepatic gluconeogenesis and hyperglycemia in genetically diabetic (C57BL/KsJ-db/db) mice.
    Kodama H; Fujita M; Yamazaki M; Yamaguchi I
    Jpn J Pharmacol; 1994 Nov; 66(3):281-7. PubMed ID: 7869614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
    Soman V; Felig P
    J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central adrenergic suppression augments the insulin and glucagon secretory, and the glycogenolytic responses in streptozotocin-diabetic rats.
    Dunbar JC; Colemen ER; Shaffer LR; Marzouq L
    Horm Res; 1991; 36(1-2):80-5. PubMed ID: 1814806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxicity induced by diethylnitrosamine causes no significant disturbances of systemic glucose homeostasis in rats.
    Hwang DL; Lev-Ran A; Tay YC; De Meyts P
    Horm Metab Res; 1990 Sep; 22(9):462-6. PubMed ID: 2175290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog.
    Edgerton DS; Cardin S; Neal D; Farmer B; Lautz M; Pan C; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E510-22. PubMed ID: 14644767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon: the effects of its excess and deficiency on insulin action.
    Fanelli CG; Porcellati F; Rossetti P; Bolli GB
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S28-34. PubMed ID: 16530126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia.
    Bhathena SJ; Voyles NR; Smith S; Recant L
    J Clin Invest; 1978 Jun; 61(6):1488-97. PubMed ID: 207737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the hepatic response to glucagon: role of insulin, growth hormone and cortisol.
    Dunbar JC; Schultz S; Houser F; Walker J
    Horm Res; 1989; 31(5-6):244-9. PubMed ID: 2693309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of inducing physiological hyperglucagonemia on metabolic responses to exercise.
    Bélanger P; Fillion Y; Couturier K; Gauthier MS; Lavoie JM
    Eur J Appl Physiol; 2003 Mar; 89(1):8-13. PubMed ID: 12627299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
    Liang Y; Cincotta AH
    Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antioxidants L-ascorbic acid and alpha-tocopherol supplementation in nickel exposed hyperglycemic rats.
    Tikare SN; Das Gupta A; Dhundasi SA; Das KK
    J Basic Clin Physiol Pharmacol; 2008; 19(2):89-101. PubMed ID: 19024927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.